- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
1861
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1861 companies
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret
Market Cap: ₺2.4b
A biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey.
ANGEN
₺11.03
7D
0.3%
1Y
-13.8%
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret
Market Cap: ₺1.5b
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.
RTALB
₺3.01
7D
-1.3%
1Y
19.6%
Fortress Biotech
Market Cap: US$50.2m
A biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products.
FBIO
US$1.73
7D
-2.8%
1Y
-6.0%
Amicus Therapeutics
Market Cap: US$2.0b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$6.26
7D
5.2%
1Y
-33.9%
IRLAB Therapeutics
Market Cap: SEK 363.6m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 7.01
7D
-3.3%
1Y
-55.6%
Level Bio
Market Cap: SEK 27.8m
Designs, develops, and distributes diagnostics products in the Nordic region and internationally.
LEVBIO
SEK 0.42
7D
4.5%
1Y
30.6%
Santhera Pharmaceuticals Holding
Market Cap: CHF 158.1m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANN
CHF 12.28
7D
-5.0%
1Y
29.3%
Processa Pharmaceuticals
Market Cap: US$1.3m
A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.
PCSA
US$0.24
7D
-1.5%
1Y
-86.2%
Xencor
Market Cap: US$535.2m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.
XNCR
US$7.69
7D
-6.2%
1Y
-67.6%
ICON
Market Cap: US$10.1b
A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
ICLR
US$126.99
7D
-2.8%
1Y
-60.3%
Heidelberg Pharma
Market Cap: €155.7m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.
HPHA
€3.34
7D
4.4%
1Y
12.1%
InterCure
Market Cap: ₪266.3m
Engages in the research, marketing, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.
INCR
₪5.65
7D
2.3%
1Y
-50.6%
Siegfried Holding
Market Cap: CHF 4.2b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 94.90
7D
0.1%
1Y
5.8%
Innate Pharma
Market Cap: €181.4m
Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.
IPH
€1.97
7D
2.5%
1Y
-26.3%
Biovica International
Market Cap: SEK 82.3m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.
BIOVIC B
SEK 0.84
7D
-5.2%
1Y
-51.9%
eXoZymes
Market Cap: US$126.7m
A development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes, while maintaining and capturing new fundamental IP in the application.
EXOZ
US$14.60
7D
7.7%
1Y
n/a
Pluri
Market Cap: US$35.2m
A biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries.
PLUR
US$4.50
7D
-10.7%
1Y
-27.1%
Pfizer
Market Cap: US$131.0b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$23.04
7D
1.9%
1Y
-19.7%
Prime Medicine
Market Cap: US$157.2m
A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.
PRME
US$1.23
7D
-2.4%
1Y
-82.3%
DanCann Pharma
Market Cap: DKK 6.5m
A biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas.
DANCAN
DKK 1.64
7D
39.0%
1Y
-97.5%
UBI Pharma
Market Cap: NT$1.7b
UBI Pharma Inc. develops, manufactures, and sells pharmaceutical products in Taiwan.
6562
NT$14.25
7D
1.8%
1Y
-62.3%
Sharp Therapeutics
Market Cap: CA$55.4m
A preclinical-stage drug discovery company, developes therapeutics for genetic diseases.
SHRX
CA$1.85
7D
0%
1Y
n/a
Kanabo Group
Market Cap: UK£1.4m
A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.
KNB
UK£0.0022
7D
0%
1Y
-85.9%
Hunan Fangsheng Pharmaceutical
Market Cap: CN¥4.3b
Researches, develops, produces, and sells pharmaceutical products in China.
603998
CN¥9.84
7D
-0.1%
1Y
-16.7%
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
Market Cap: HK$7.0b
Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.
1349
HK$2.63
7D
1.9%
1Y
22.3%
Vitura Health
Market Cap: AU$45.0m
Engages in the sale and distribution of medicinal cannabis products in Australia.
VIT
AU$0.068
7D
-2.9%
1Y
-26.9%
Wuhan Hiteck Biological PharmaLtd
Market Cap: CN¥3.1b
A biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China.
300683
CN¥24.02
7D
2.0%
1Y
-0.2%
Suzhou Zelgen BiopharmaceuticalsLtd
Market Cap: CN¥26.2b
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
688266
CN¥99.00
7D
7.4%
1Y
80.8%
Gujarat Terce Laboratories
Market Cap: ₹429.7m
Develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally.
524314
₹57.91
7D
-1.2%
1Y
5.6%
AIM Vaccine
Market Cap: HK$5.1b
Researches, develops, manufactures, and commercializes of vaccine products for human use in the People’s Republic of China.
6660
HK$4.15
7D
25.4%
1Y
-44.5%
Indo-Bangla Pharmaceuticals
Market Cap: ৳1.1b
Engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally.
IBP
৳9.20
7D
5.7%
1Y
-32.8%
Beijing Sun-Novo Pharmaceutical Research
Market Cap: CN¥4.9b
A contract research company, engages in the research and development of drugs in China.
688621
CN¥44.95
7D
4.5%
1Y
-11.3%
Guangdong VTR Bio-Tech
Market Cap: CN¥3.7b
Researches, develops, produces, sells, and services biological enzyme preparations, biosynthetics, and nutrition and health products in China.
300381
CN¥7.71
7D
-1.7%
1Y
7.8%
Ningbo Menovo Pharmaceutical
Market Cap: CN¥3.1b
Research, develops, produces, and sells pharmaceutical products.
603538
CN¥14.20
7D
2.9%
1Y
10.1%
Theragen EtexLtd
Market Cap: ₩110.6b
Engages in the research and development, production, and sale of pharmaceutical products in Korea.
A066700
₩3,015.00
7D
-0.2%
1Y
-22.8%
Bilcare
Market Cap: ₹1.8b
Provides pharmaceutical packaging research solutions in India and internationally.
526853
₹76.72
7D
2.4%
1Y
18.2%